Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Respiratory Cell and Molecular Biology|January 26, 2005
B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombinationTakechiyo Yamada, Ke Zhang, Akiko Yamada, et al.
The Journal of Allergy and Clinical Immunology|June 5, 2007
Modifications to an Fcgamma-Fcvarepsilon fusion protein alter its effectiveness in the inhibition of FcvarepsilonRI-mediated functionsLisa Chan Allen, Christopher L Kepley, Andrew Saxon, et al.
Immunology and Allergy Clinics of North America|February 6, 2007
Chimeric human fcgamma-allergen fusion proteins in the prevention of allergyKe Zhang, Daocheng Zhu, Christopher Kepley, et al.
The Journal of Allergy and Clinical Immunology|May 9, 2009
IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptorAnne Behnecke, Wei Li, Ling Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigenMarc A Riedl, Elliot M Landaw, Andrew Saxon, et al.
Current Opinion in Allergy and Clinical Immunology|January 11, 2005
Genetically engineered negative signaling molecules in the immunomodulation of allergic diseasesAndrew Saxon, Daocheng Zhu, Ke Zhang, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseasesAndrew Saxon, Daocheng Zhu, Ke Zhang, et al.
Pageof 5